TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.72%)
As of: Sep 9, 2026 · 2:01 PM EDT

TAO Synergies (TAOX) Retained Earnings (2020 - 2026)

TAO Synergies' (TAOX) quarterly Retained Earnings came in at $94.4 million in Q2 2026, up 15.46% on a YoY basis from $81.7 million in Q2 2025, and down 1.06% quarter-over-quarter from $95.4 million in Q1 2026.

Analysis

TAO Synergies (TAOX) Retained Earnings (2020 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Retained Earnings for 7 consecutive years, with $94.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings rose 15.46% year-over-year to $94.4 million; the trailing twelve-month figure through Jun 2026 stood at $94.4 million (up 15.46% YoY), and the FY2025 full-year result was $97.2 million, up 83.38% from the prior year.
  • Retained Earnings eased to $94.4 million in Q2 2026 per TAOX's latest filing, from $95.4 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $97.2 million in Q4 2025 and bottomed at $49.1 million in Q1 2022.
  • Historically, Retained Earnings has averaged $64.0 million across 5 years, with a median of $55.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings soared 144.38% in 2022, then decreased 8.51% in 2024.
  • Over 5 years, Retained Earnings stood at $52.5 million in 2022, then rose by 10.34% to $58.0 million in 2023, then declined by 8.51% to $53.0 million in 2024, then surged by 83.38% to $97.2 million in 2025, then slipped by 2.93% to $94.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $94.4 million, $95.4 million, and $97.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 210.98 Bn 196.99 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 181.24 Bn 178.06 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 132.38 Bn 124.53 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 82.97 Bn 74.97 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.80 Bn 49.67 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 34.09 Bn 30.78 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.34 Bn 30.05 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn 5.13 Bn
10 TAO Synergies 30.79 Mn 30.79 Mn - 94.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.39 Mn
Mar 31, 2026 95.40 Mn
Dec 31, 2025 97.24 Mn
Sep 30, 2025 84.53 Mn
Jun 30, 2025 81.75 Mn
Mar 31, 2025 52.05 Mn
Dec 31, 2024 53.03 Mn
Sep 30, 2024 54.31 Mn
Jun 30, 2024 54.26 Mn
Mar 31, 2024 56.09 Mn
Dec 31, 2023 57.96 Mn
Sep 30, 2023 59.12 Mn
Jun 30, 2023 56.85 Mn
Mar 31, 2023 53.27 Mn
Dec 31, 2022 52.52 Mn
Sep 30, 2022 50.86 Mn
Jun 30, 2022 50.12 Mn
Mar 31, 2022 49.10 Mn
Dec 31, 2021 47.67 Mn
Sep 30, 2021 41.26 Mn